Comparative Pharmacology
Head-to-head clinical analysis: BROMPHENIRAMINE MALEATE PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE versus WYAMINE SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BROMPHENIRAMINE MALEATE PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE versus WYAMINE SULFATE.
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE vs WYAMINE SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Brompheniramine is a first-generation antihistamine that competitively inhibits histamine at H1 receptors, reducing allergic symptoms. Pseudoephedrine is a sympathomimetic amine that directly stimulates alpha-adrenergic receptors, causing vasoconstriction and nasal decongestion. Dextromethorphan is an NMDA receptor antagonist and sigma-1 receptor agonist that suppresses the cough reflex in the medulla oblongata.
Wyamine sulfate (mephentermine sulfate) is a sympathomimetic amine that acts primarily by releasing norepinephrine from presynaptic nerve terminals, with direct alpha- and beta-adrenergic receptor agonist activity. It causes vasoconstriction and positive inotropic effects, increasing cardiac output and blood pressure.
Adults and children ≥12 years: 1 tablet (brompheniramine maleate 4 mg, pseudoephedrine HCl 60 mg, dextromethorphan HBr 15 mg) orally every 4 hours, not to exceed 4 tablets in 24 hours, or 2 tablets (extended-release) every 12 hours, not to exceed 4 tablets in 24 hours.
Intramuscular injection: 15-30 mg as a single dose; may repeat in 10-15 minutes if needed. Maximum total dose: 60 mg.
None Documented
None Documented
Brompheniramine: 12-34 hours (mean ~24 h), prolonged in hepatic impairment. Pseudoephedrine: 5-8 hours (pH-dependent urinary excretion; alkaline urine prolongs half-life). Dextromethorphan: 3-4 hours (extensive metabolizers) or 18-24 hours (poor metabolizers of CYP2D6).
Terminal elimination half-life is 6-8 hours in adults with normal renal function (CrCl >90 mL/min).
Brompheniramine: Renal (approx. 80% as metabolites, <1% unchanged). Pseudoephedrine: Renal (70-90% unchanged, rest as metabolites). Dextromethorphan: Renal (primarily as metabolites, <1% unchanged). Biliary/fecal: Minor for all three.
Primarily renal; 90% excreted unchanged in urine within 24 hours. Minimal biliary/fecal elimination (<5%).
Category A/B
Category C
Sympathomimetic
Sympathomimetic